Md. biopharm Neuralstem aims to raise under $6m in stock offering

Germantown-based Neuralstem Inc., a biopharmaceutical firm developing treatments for nervous system diseases on Thursday announced plans to raise less than $6 million through an underwritten public offering. Neuralstem will offer 3 million shares of common stock and warrants to purchase up to 2.25 million shares of common stock at a purchase price of $2.00 per share of common stock and …


Author: Baltimore Checkbook

Best in consumer news and deals in Baltimore, MD.

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s